Showing results (2041-2050 of 6,943) with videos related to
Sort By:
Pageof 695
Cancer Science|September 28, 2022
Clinical impact of bile-derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancersMichihiro Yoshida, Hiroshi Yukawa, Kazuki Hayashi, et al.Cancer Science|May 24, 2011
Prognostic role of CD10⁺ myeloid cells in association with tumor budding at the invasion front of colorectal cancerDo Trong Khanh, Eiji Mekata, Ken-ichi Mukaisho, et al.Cancer Science|May 26, 2011
Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 indexYoshizo Kimura, Kensaku Sato, Yutaka Imamura, et al.Cancer Science|July 5, 2011
Interference of E2-2-mediated effect in endothelial cells by FAM96B through its limited expression of E2-2Weiwen Yang, Fumiko Itoh, Hirotoshi Ohya, et al.Cancer Science|July 26, 2011
Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-MycChih-Pin Chuu, John M Kokontis, Richard A Hiipakka, et al.Cancer Science|July 16, 2011
Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese menFang Liu, Ann W Hsing, Xiang Wang, et al.Cancer Science|June 15, 2011
Downregulation of Cockayne syndrome B protein reduces human 8-oxoguanine DNA glycosylase-1 expression and repair of UV radiation-induced 8-oxo-7,8-dihydro-2'-deoxyguanineArash Javeri, James Guy Lyons, Xiao X Huang, et al.Cancer Science|June 29, 2011
EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cellsChul-Yong Park, Dae-Kee Kim, Yhun Yhong SheenCancer Science|July 2, 2011
Overexpression of neurone glial-related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancerJason Y Chan, Chee W Ong, Manuel Salto-TellezCancer Science|July 12, 2011
Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphismsTaroh Satoh, Takashi Ura, Yasuhide Yamada, et al.Pageof 695